1. Home
  2. STIM vs STHO Comparison

STIM vs STHO Comparison

Compare STIM & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.02

Market Cap

95.6M

Sector

Health Care

ML Signal

HOLD

STHO

Star Holdings Shares of Beneficial Interest

HOLD

Current Price

$8.48

Market Cap

101.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
STHO
Founded
2003
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
95.6M
101.5M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
STIM
STHO
Price
$2.02
$8.48
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.8M
22.8K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
57.25
24.73
EPS
N/A
N/A
Revenue
$52,776,000.00
$110,143,000.00
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$6.06
52 Week High
$4.84
$9.24

Technical Indicators

Market Signals
Indicator
STIM
STHO
Relative Strength Index (RSI) 69.40 56.16
Support Level $1.23 $8.20
Resistance Level $2.13 $8.61
Average True Range (ATR) 0.14 0.20
MACD 0.05 0.01
Stochastic Oscillator 84.90 72.92

Price Performance

Historical Comparison
STIM
STHO

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.

Share on Social Networks: